04.11.2012 • News

Applikon, Thermo Fisher Sign Bilateral Supply Agreement

Applikon Biotechnology, a global supplier of bioreactor control systems to the biopharma market, today announced the signing of a bilateral supply agreement with Thermo Fisher Scientific.

As part of the agreement, Thermo Fisher and Applikon have developed an integrated solution that combines the Thermo Scientific HyClone Single-Use Bioreactor (S.U.B.) with the Applikon ez- and i-Control systems.

Thermo Scientific will resell this solution under the Thermo Scientific HyPerforma product suite. Applikon will resell the S.U.B. as a integrated solution.

 

Interview

Leading Transformation
The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read